Search - tctmd.com

Displaying 21 - 40 of 1109

Sort: Relevancy | Date

Presentation TCT 2016

BRS in STEMI: Rationale and Technique Differences Compared to Stable Lesions

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Roberto Diletti

November 01, 2016

Presentation TCT 2016

BRS in Small Vessels and Diffuse Disease Rapid-Fire Case Reviews

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Kenneth Chin

November 01, 2016

Presentation TCT 2016

BRS in Small Vessels and Diffuse Disease: Managing Overlapping Scaffolds; When to Use DES or Balloon Only

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Jorge A. Belardi

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: ReACT

Presenter: Giulio Guagliumi, Ik-Kyung Jang, Niels R. Holm

November 01, 2016

Presentation TCT 2016

BRS CTO Rapid-Fire Case Reviews

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Julinda Mehilli

November 01, 2016

Presentation TCT 2016

BRS in CTOs: Why and How

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Jochen Wöhrle

November 01, 2016

Presentation TCT 2016

BRS Bifurcation Rapid-Fire Case Reviews

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Manuel Pan

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Presenter: Giulio Guagliumi, Ik-Kyung Jang, Ron Waksman

November 01, 2016

Presentation TCT 2016

Bifurcations and BRS: Techniques, Full Polymer, or Hybrid?

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Azeem Latib

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Presenter: Adrian P. Banning, Nick Curzen, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

Diagnosis and Treatment of Erosion in ACS: The EROSION Study

Presenter: John A. Ambrose, Peter H. Stone, Ik-Kyung Jang

November 01, 2016

Presentation TCT 2016

Bayesian Statistics: Utility and Interpretation

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Marc Etienne Jolicoeur

November 01, 2016

Presentation TCT 2016

Propensity-Matched Analysis: Advantages and Pitfalls

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Tracy Y. Wang

November 01, 2016

Presentation TCT 2016

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Somjot S. Brar

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Subgroup Analyses: How Useful or Harmful Are They?

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Sanjay Kaul

November 01, 2016

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

Presentation TCT 2016

Use of Intravascular Imaging in CTO Intervention

Presenter: Ik-Kyung Jang, Matthew J. Price, Yasushi Asakura

October 31, 2016

Presentation TCT 2016

Back to BRS: Falcon, the Next Generation

Presenter: Ron Waksman, Robert-Jan van Geuns, Richard J. Rapoza

October 31, 2016

Advertisement

BRS in STEMI: Rationale and Technique Differences Compared to Stable Lesions

BRS in Small Vessels and Diffuse Disease Rapid-Fire Case Reviews

BRS in Small Vessels and Diffuse Disease: Managing Overlapping Scaffolds; When to Use DES or Balloon Only

Highlights (and my Interpretations) From: ReACT

BRS CTO Rapid-Fire Case Reviews

BRS in CTOs: Why and How

BRS Bifurcation Rapid-Fire Case Reviews

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Bifurcations and BRS: Techniques, Full Polymer, or Hybrid?

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Diagnosis and Treatment of Erosion in ACS: The EROSION Study

Bayesian Statistics: Utility and Interpretation

Propensity-Matched Analysis: Advantages and Pitfalls

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Subgroup Analyses: How Useful or Harmful Are They?

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Use of Intravascular Imaging in CTO Intervention

Back to BRS: Falcon, the Next Generation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content